ADN CHART, page-2212

I can see the point entirely.
How could anyone provide a price for "on the shelf", over the counter or for prescription medicines, whether they are an essential ingredient or whether these fine and to a large extent innocuous ingredients assist in delivery and absorption of the prescribed material? such uses would increase the value of the constituent ingredient 10 000 fold once appropriately refined and verified.
2020 is going to be a great year for ADN. if you do not hold and represent an adverse predisposition to the stock with valid credence, I recommend to myself...and others here move on.....